Skip to main content
. 2018 Aug 10;7:1235. [Version 1] doi: 10.12688/f1000research.15789.1

Table 1. Survival information and protein summary available in TRGAted.

Cancer Type Samples OS DSS DFI PFI Proteins
Adrenocortical carcinoma (ACC) 46 46 46 28 46 221
Bladder Urothelial Carcinoma (BLCA) 344 344 330 153 344 223
Breast invasive carcinoma (BRCA) 901 873 855 750 873 224
Cervical squamous cell carcinoma
and endocervical adenocarcinoma
(CESC)
171 171 168 112 171 220
Cholangiocarcinoma (CHOL) 30 30 29 21 30 219
Colon adenocarcinoma (COAD) 358 325 311 126 325 223
Diffuse Large B-cell Lymphoma
(DLBCL)
33 33 33 19 33 219
Esophageal carcinoma (ESCA) 126 126 124 76 126 220
Glioblastoma multiforme (GBM) 205 136 123 0 136 223
Head and Neck squamous cell
carcinoma (HNSC)
346 346 326 85 346 239
Kidney Chromophobe (KICH) 63 63 63 27 63 220
Kidney renal clear cell carcinoma
(KIRC)
445 444 434 72 444 233
Kidney renal papillary cell carcinoma
(KIRP)
208 207 205 127 207 221
Lower Grade Glioma (LGG) 427 426 420 114 426 220
Liver hepatocellular carcinoma (LIHC) 184 184 177 145 184 220
Lung adenocarcinoma (LUAD) 362 361 327 203 361 239
Lung squamous cell carcinoma
(LUSC)
325 325 295 210 325 239
Mesothelioma (MESO) 61 61 45 10 61 220
Ovarian serous cystadenocarcinoma
(OV)
411 405 377 199 407 224
Pancreatic adenocarcinoma (PAAD) 105 105 99 40 105 221
Pheochromocytoma and
Paraganglioma (PCPG)
81 79 79 71 79 220
Prostate adenocarcinoma (PRAD) 351 351 350 233 351 220
Rectum adenocarcinoma (READ) 130 126 120 31 126 223
Sarcoma (SARC) 221 221 215 125 22 220
Skin Cutaneous Melanoma (SKCM) 354 349 346 0 349 223
Stomach adenocarcinoma (STAD) 392 357 334 207 357 220
Testicular Germ Cell Tumors (TGCT) 118 104 104 79 104 219
Thyroid carcinoma (THCA) 374 372 366 268 372 219
Thymoma (THYM) 90 90 90 9 90 219
Uterine Corpus Endometrial
Carcinoma (UCEC)
404 404 403 325 404 223
Uterine Carcinosarcoma (UCS) 48 48 46 22 48 220

OS, overall survival; DSS, disease-specific survival; DFI, disease-free interval; PFI, progression-free interval.